Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
04.06.21 | Basilea Pharmaceutica - Multiple catalysts on the horizon | 415 | Edison Investment Research | Basilea has provided an update on the three ongoing derazantinib Phase II trials (FIDES-01/02/03) that will define its utility in iCCA (bile duct cancer), urothelial cancer (UC) and gastric cancer (GC).... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
VARTA | 2.283 |
TUI | 2.228 |
RHEINMETALL | 2.128 |
NEL | 1.901 |
RENK GROUP | 1.434 |
NVIDIA | 1.394 |
DEUTSCHE LUFTHANSA | 1.391 |
TESLA | 1.367 |
BAYER | 1.092 |
AIXTRON SE | 1.070 |
BYD | 919 |
SARTORIUS AG VZ | 758 |
NETFLIX | 683 |
DEUTSCHE BANK | 676 |
EVOTEC | 662 |
BASF | 655 |
RWE | 625 |
ALLIANZ | 542 |
BARRICK GOLD | 537 |
HENSOLDT | 529 |
SUPER MICRO COMPUTER | 529 |
MERCEDES-BENZ | 525 |
INFINEON | 524 |
COMMERZBANK | 512 |
PLUG POWER | 487 |